Arql股票zacks hidphhq

Arql股票zacks

13.10.2020

Ronco29579

Online Stock Trading, Investing, Online Brokerage | TD ... The online brokerage that makes you a smarter investor Our knowledgeable professionals and industry leading tools are united to do one thing: make you a smarter, more confident investor. Open new account Learn more. When the market swings, learn how to swing back. Get expert insights to help navigate the ups and downs of the market with ER move 一览表 < ER系列 > - 钱多多股票论坛 www.trader1688.com Oct 27, 2006 務實且有潛力的新藥公司 >> 必富未上市財經網‧未上市股票股價‧未 … 未上市,未上市股票,未上市櫃股票,未上市股票買賣,未上市選擇,未上市買賣,未上市股票,未上市股,未上市,未上市櫃股票,未上市-必富未上市股票財經資訊網,必富未上市股票財經資訊網提供未上市之即時參考價、趨勢圖、歷史股價等等，對於未上市之股票市場而言，大多數的公司屬於成長型，因此若能 Zacks Industry Rank Education-- Learn more about the Zacks Industry Rank ArQule, Inc. (ARQL) Quote Overview » Estimates » ArQule, Inc. (ARQL) Detailed Estimates Detailed Estimates

FINVIZ.com - Stock Screener

Scotts Miracle-Gro raises full-year earnings, revenue guidance. Scotts Miracle-Gro (NYSE:SMG) +5.5% after-hours after raising its FY 2020 forecast for adjusted EPS to $5.65-5.85 from previous ARQL: NA equity research. Get the latest equity research information from Zacks Investment Research. (arql)股票公司摘要,信息或数据由新浪财经美股频道提供

2019年12月25日 The product carries a Zacks ETF Rank #3 with a High risk outlook . 同意分别收购规模较小的癌症药物制造商ArQle ARQL 和Synthorx THOR 。

Shares of ArQule, Inc. ARQL jumped 103.9% after Merck & Co., Inc. said it would buy the company in a deal worth $2.7 billion. Shares of Synthorx, Inc. THOR soared 170.5% after Sanofi SA said that it will acquire the company for an aggregated equity value of around $2.5 billion. Shares of Canopy Growth Corporation CGC rose 14.2% after the company announced David Klein as the new CEO QCOM Stock Price | Qualcomm Inc. Stock Quote (U.S.: Nasdaq ...

According to Zacks Investment Research, "ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer.

未上市,未上市股票,未上市櫃股票,未上市股票買賣,未上市選擇,未上市買賣,未上市股票,未上市股,未上市,未上市櫃股票,未上市-必富未上市股票財經資訊網,必富未上市股票財經資訊網提供未上市之即時參考價、趨勢圖、歷史股價等等，對於未上市之股票市場而言，大多數的公司屬於成長型，因此若能 Zacks Industry Rank Education-- Learn more about the Zacks Industry Rank ArQule, Inc. (ARQL) Quote Overview » Estimates » ArQule, Inc. (ARQL) Detailed Estimates Detailed Estimates ARQL: NA - Companarative Chart. Get the latest Comparative Chart for NA from Zacks Investment Research ARQL: What are Zacks experts saying now? Zacks Private Portfolio Services. Merck to Buy ArQule for $2.7B to Boost Cancer Portfolio 12/10/19-8:42AM EST Zacks Company News for Dec 10, 2019 ARQL: NA equity research. Get the latest equity research information from Zacks Investment Research.